Cargando…

Tissue dose estimation after extravasation of (177)Lu-DOTATATE

BACKGROUND: Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations requires the preliminary estimation of the dose distribution i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tylski, Perrine, Pina-Jomir, Géraldine, Bournaud-Salinas, Claire, Jalade, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012450/
https://www.ncbi.nlm.nih.gov/pubmed/33788043
http://dx.doi.org/10.1186/s40658-021-00378-3
_version_ 1783673368213454848
author Tylski, Perrine
Pina-Jomir, Géraldine
Bournaud-Salinas, Claire
Jalade, Patrice
author_facet Tylski, Perrine
Pina-Jomir, Géraldine
Bournaud-Salinas, Claire
Jalade, Patrice
author_sort Tylski, Perrine
collection PubMed
description BACKGROUND: Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations requires the preliminary estimation of the dose distribution in the extravasation area. Data are scarce regarding the dose estimation in the literature. This work presents a methodology for estimating the dose distribution after an extravasation occurred in September 2017, in the arm of a patient during a 7.4-GBq infusion of Lutathera ® (AAA). METHODS: A local quantification procedure initially developed for renal dosimetry was used. A calibration factor was determined and verified by phantom study. Extravasation volume of interest and its variation in time were determined using 4 whole body (WB) planar acquisitions performed at 2 h (T(2h)), 5 h (T(5h)), 20 h (T(20h)), and 26 h (T(26h)) after the beginning of the infusion and three SPECT/CT thoracic acquisitions at T(5h), T(20h), and T(26h). For better estimation of initial extravasation volume, 3 volumes were defined on SPECT images using a 3D activity threshold. Cumulated activities and associated absorbed doses (D(1), D(2), D(3)) were calculated in the 3 volumes using the MIRD formalism. RESULTS: Volumes estimated using 3D threshold were V(1) = 1000 mL, V(2) =400 mL, and V(3) =180 mL. Cumulated activities were evaluated using a monoexponential fit on activities calculated on SPECT images. Estimated local absorbed doses in V(1), V(2), and V(3) were D(1) = 2.3 Gy, D(2) = 4.1 Gy, and D(3) = 6.8 Gy. Evolution in time of local activity in the extravasation area was consistent with an effective local half-life (T(eff)) of 2.3 h. CONCLUSIONS: Rapid local dose estimation was permitted thanks to knowledge of the calibration factor determined previous to accidental extravasation. Lutathera® lymphatic drainage was quick in the arm (T(eff) = 2.3h). Estimated doses were in the lower range of deterministic effects and far under soft tissue necrosis threshold. Thus, no surgical rinse was proposed. The patient did not show any clinical consequence of the extravasation.
format Online
Article
Text
id pubmed-8012450
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80124502021-04-16 Tissue dose estimation after extravasation of (177)Lu-DOTATATE Tylski, Perrine Pina-Jomir, Géraldine Bournaud-Salinas, Claire Jalade, Patrice EJNMMI Phys Original Research BACKGROUND: Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations requires the preliminary estimation of the dose distribution in the extravasation area. Data are scarce regarding the dose estimation in the literature. This work presents a methodology for estimating the dose distribution after an extravasation occurred in September 2017, in the arm of a patient during a 7.4-GBq infusion of Lutathera ® (AAA). METHODS: A local quantification procedure initially developed for renal dosimetry was used. A calibration factor was determined and verified by phantom study. Extravasation volume of interest and its variation in time were determined using 4 whole body (WB) planar acquisitions performed at 2 h (T(2h)), 5 h (T(5h)), 20 h (T(20h)), and 26 h (T(26h)) after the beginning of the infusion and three SPECT/CT thoracic acquisitions at T(5h), T(20h), and T(26h). For better estimation of initial extravasation volume, 3 volumes were defined on SPECT images using a 3D activity threshold. Cumulated activities and associated absorbed doses (D(1), D(2), D(3)) were calculated in the 3 volumes using the MIRD formalism. RESULTS: Volumes estimated using 3D threshold were V(1) = 1000 mL, V(2) =400 mL, and V(3) =180 mL. Cumulated activities were evaluated using a monoexponential fit on activities calculated on SPECT images. Estimated local absorbed doses in V(1), V(2), and V(3) were D(1) = 2.3 Gy, D(2) = 4.1 Gy, and D(3) = 6.8 Gy. Evolution in time of local activity in the extravasation area was consistent with an effective local half-life (T(eff)) of 2.3 h. CONCLUSIONS: Rapid local dose estimation was permitted thanks to knowledge of the calibration factor determined previous to accidental extravasation. Lutathera® lymphatic drainage was quick in the arm (T(eff) = 2.3h). Estimated doses were in the lower range of deterministic effects and far under soft tissue necrosis threshold. Thus, no surgical rinse was proposed. The patient did not show any clinical consequence of the extravasation. Springer International Publishing 2021-03-31 /pmc/articles/PMC8012450/ /pubmed/33788043 http://dx.doi.org/10.1186/s40658-021-00378-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Tylski, Perrine
Pina-Jomir, Géraldine
Bournaud-Salinas, Claire
Jalade, Patrice
Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title_full Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title_fullStr Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title_full_unstemmed Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title_short Tissue dose estimation after extravasation of (177)Lu-DOTATATE
title_sort tissue dose estimation after extravasation of (177)lu-dotatate
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012450/
https://www.ncbi.nlm.nih.gov/pubmed/33788043
http://dx.doi.org/10.1186/s40658-021-00378-3
work_keys_str_mv AT tylskiperrine tissuedoseestimationafterextravasationof177ludotatate
AT pinajomirgeraldine tissuedoseestimationafterextravasationof177ludotatate
AT bournaudsalinasclaire tissuedoseestimationafterextravasationof177ludotatate
AT jaladepatrice tissuedoseestimationafterextravasationof177ludotatate